Replies to post #11977 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Couldn't agree more.

Indivior's results aren't as good as Titan's were in 2013. So why it isn't an automatic CRL?

Big Pharma runs the FDA.

[KMBJN]

Yep - RBP-6000 has priority review:

https://finance.yahoo.com/news/indivior-plc-announces-fda-acceptance-123000019.html

Am looking forward to the Advisory Committee shoo-in (grilling?) and FDA decision.

Someone I know who does pharmaceutical consulting thought that addiction doctors would be less likely to implant probuphine since they might not see patients for 6 months, versus a 1 month implant pretty much requires them to come back for more treatment. As a patient, I would want 6 month implant versus monthly shots, but I don't think doctors always do what is best for patients, unfortunately. Not as much involved with a shot versus implant, so probably won't have to worry about reimbursement there.